DocuSign introduces DocuSign Ventures for pushing the future of agreements
Over the current book year the company from San Francisco could achieve a revenue around 2.09 billion USD (consensus estimates). This is quite more than 2021's revenue of 1.45 billion USD.
Historical revenues and results DocuSign plus estimates 2021
The analysts expect for 2021 a net profit of 364 million USD. For this year the consensus of DocuSign 's result per share is a profit of 1.75 USD. The PE-ratio therefore is a significant 155.94.
Analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies is an attractive 2.64 percent.
Based on the current number of outstanding shares DocuSign 's market capitalization is 49.46 billion USD. 20
At 22.00 the stock trades 0.6 percent lower at 272.89 USD.Historical stock prices DocuSign past 10 years
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x |
